Financial News
Crispr Therapeutics Ag (NQ: CRSP )
Historical Prices
Year:
| Date | Open | High | Low | Close | Volume | Change (%) |
|---|---|---|---|---|---|---|
| Apr 30, 2021 | 129.71 | 135.13 | 129.69 | 131.27 | 957,000 | -0.61(-0.46%) |
| Apr 29, 2021 | 136.66 | 136.72 | 129.10 | 131.88 | 1,168,703 | -3.66(-2.70%) |
| Apr 28, 2021 | 129.85 | 136.24 | 128.25 | 135.54 | 1,275,716 | +2.50(+1.88%) |
| Apr 27, 2021 | 136.91 | 137.25 | 129.67 | 133.04 | 1,302,999 | -2.68(-1.97%) |
| Apr 26, 2021 | 128.22 | 137.59 | 126.60 | 135.72 | 1,999,949 | +9.17(+7.25%) |
| Apr 23, 2021 | 125.50 | 128.42 | 123.60 | 126.55 | 1,097,400 | +0.66(+0.52%) |
| Apr 22, 2021 | 127.50 | 130.28 | 123.84 | 125.89 | 1,738,145 | +0.96(+0.77%) |
| Apr 21, 2021 | 123.00 | 129.50 | 120.78 | 124.93 | 3,118,926 | +3.26(+2.68%) |
| Apr 20, 2021 | 122.00 | 125.48 | 117.38 | 121.67 | 2,621,499 | +6.63(+5.76%) |
| Apr 19, 2021 | 117.12 | 120.00 | 112.99 | 115.04 | 1,154,206 | -3.52(-2.97%) |
| Apr 16, 2021 | 123.41 | 123.70 | 116.20 | 118.56 | 1,359,200 | -5.29(-4.27%) |
| Apr 15, 2021 | 125.00 | 126.70 | 121.83 | 123.85 | 896,041 | +0.74(+0.60%) |
| Apr 14, 2021 | 122.91 | 129.27 | 122.32 | 123.11 | 1,913,433 | +2.23(+1.84%) |
| Apr 13, 2021 | 114.21 | 122.48 | 114.21 | 120.88 | 1,351,679 | +6.49(+5.67%) |
| Apr 12, 2021 | 115.01 | 116.10 | 111.34 | 114.39 | 1,080,581 | -1.35(-1.17%) |
| Apr 09, 2021 | 119.28 | 119.37 | 114.32 | 115.74 | 1,068,200 | -4.64(-3.85%) |
| Apr 08, 2021 | 119.52 | 122.00 | 117.61 | 120.38 | 927,781 | +1.85(+1.56%) |
| Apr 07, 2021 | 120.53 | 123.50 | 117.80 | 118.53 | 753,805 | -3.10(-2.55%) |
| Apr 06, 2021 | 120.50 | 125.51 | 118.73 | 121.63 | 1,162,908 | -0.37(-0.30%) |
| Apr 05, 2021 | 122.17 | 124.40 | 118.86 | 122.00 | 947,622 | +2.59(+2.17%) |
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
